1. Home
  2. TNXP vs WAVE Comparison

TNXP vs WAVE Comparison

Compare TNXP & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$12.70

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

HOLD

Current Price

$8.75

Market Cap

29.4M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNXP
WAVE
Founded
2007
2011
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
198.6M
29.4M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
TNXP
WAVE
Price
$12.70
$8.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
418.4K
29.7K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
91.75
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
$558.11
$436.84
Revenue Next Year
$38.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.85
N/A
52 Week Low
$11.60
$4.52
52 Week High
$69.65
$10.50

Technical Indicators

Market Signals
Indicator
TNXP
WAVE
Relative Strength Index (RSI) 44.55 57.45
Support Level $12.43 $6.74
Resistance Level $15.19 $9.67
Average True Range (ATR) 1.12 0.71
MACD -0.19 -0.09
Stochastic Oscillator 16.07 38.18

Price Performance

Historical Comparison
TNXP
WAVE

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

Share on Social Networks: